Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrik Maurer

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Clinical Immunology (Orlando, Fla.)|July 7, 2009
Immunization against angiotensins for the treatment of hypertensionPatrik Maurer, Martin F Bachmann
Current Opinion in Molecular Therapeutics|March 2, 2006
Therapeutic vaccines for nicotine dependencePatrik Maurer, Martin F Bachmann
Expert Opinion on Investigational Drugs|November 1, 2007
Vaccination against nicotine: an emerging therapy for tobacco dependencePatrik Maurer, Martin F Bachmann
The Biochemical Journal|May 14, 2003
Characterization of SMOC-2, a modular extracellular calcium-binding proteinChristian Vannahme, Silke Gösling, Mats Paulsson, et al.
The Biochemical Journal|October 29, 2003
Characterization of a pseudoachondroplasia-associated mutation (His587-->Arg) in the C-terminal, collagen-binding domain of cartilage oligomeric matrix protein (COMP)Luitgard Spitznagel, D Patric Nitsche, Mats Paulsson, et al.
European Journal of Immunology|December 30, 2014
Protective effect of a germline, IL-17-neutralizing antibody in murine models of autoimmune inflammatory diseaseKiran Dallenbach, Patrik Maurer, Till Röhn, et al.
The Journal of Clinical Investigation|August 22, 2002
Pseudoachondroplasia is caused through both intra- and extracellular pathogenic pathwaysRobert Dinser, Frank Zaucke, Florian Kreppel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 6, 2007
TLR9 signaling in B cells determines class switch recombination to IgG2aAndrea Jegerlehner, Patrik Maurer, Juliana Bessa, et al.
Glycobiology|March 27, 2004
Structural variability of BM-40/SPARC/osteonectin glycosylation: implications for collagen affinityBrigitte Kaufmann, Stefan Müller, Franz-Georg Hanisch, et al.
The Biochemical Journal|August 16, 2002
Matrilin-2 interacts with itself and with other extracellular matrix proteinsDorothea Piecha, Charlotte Wiberg, Matthias Mörgelin, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Clinical Immunology (Orlando, Fla.)|July 7, 2009
Immunization against angiotensins for the treatment of hypertensionPatrik Maurer, Martin F Bachmann
Current Opinion in Molecular Therapeutics|March 2, 2006
Therapeutic vaccines for nicotine dependencePatrik Maurer, Martin F Bachmann
Expert Opinion on Investigational Drugs|November 1, 2007
Vaccination against nicotine: an emerging therapy for tobacco dependencePatrik Maurer, Martin F Bachmann
The Biochemical Journal|May 14, 2003
Characterization of SMOC-2, a modular extracellular calcium-binding proteinChristian Vannahme, Silke Gösling, Mats Paulsson, et al.
The Biochemical Journal|October 29, 2003
Characterization of a pseudoachondroplasia-associated mutation (His587-->Arg) in the C-terminal, collagen-binding domain of cartilage oligomeric matrix protein (COMP)Luitgard Spitznagel, D Patric Nitsche, Mats Paulsson, et al.
European Journal of Immunology|December 30, 2014
Protective effect of a germline, IL-17-neutralizing antibody in murine models of autoimmune inflammatory diseaseKiran Dallenbach, Patrik Maurer, Till Röhn, et al.
The Journal of Clinical Investigation|August 22, 2002
Pseudoachondroplasia is caused through both intra- and extracellular pathogenic pathwaysRobert Dinser, Frank Zaucke, Florian Kreppel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 6, 2007
TLR9 signaling in B cells determines class switch recombination to IgG2aAndrea Jegerlehner, Patrik Maurer, Juliana Bessa, et al.
Glycobiology|March 27, 2004
Structural variability of BM-40/SPARC/osteonectin glycosylation: implications for collagen affinityBrigitte Kaufmann, Stefan Müller, Franz-Georg Hanisch, et al.
The Biochemical Journal|August 16, 2002
Matrilin-2 interacts with itself and with other extracellular matrix proteinsDorothea Piecha, Charlotte Wiberg, Matthias Mörgelin, et al.
Pageof 3